Search
liver-organoid
Normal Organoid

Liver Organoid

5500€+
Normal Organoid

Liver Organoid

  • Replicate the complex cellular composition of the human liver, enabling in-depth studies on liver biology and function.
  • Allow for the modeling of liver diseases such as hepatitis and fibrosis, contributing to the understanding of disease mechanisms and the development of therapeutic strategies.
  • Mimic human liver metabolism, making it useful for studying drug metabolism, toxicity, and the development of personalized medicines.

Price
Organism
Human
Product Type
iPS-derived organoid
Tissue
Liver
Disease

Applications

-

Professor Lee Chang-seok Eulji University
Customer insight

Advancing K-Beauty with Skin Organoids: A Next-Generation Platform for Non-Animal Testing and High-Precision Cosmetic Innovation

With the global rise of K-beauty, the cosmetics industry continues to grow steadily. Since the ban on animal testing for cosmetics in Korea in 2017, various alternative testing methods have...

Tomocube (Spatial)
Customer insight

HT-X1: A Label-Free Imaging Breakthrough for Organoid-Based Disease Modeling and Drug Screening

Traditional microscopy methods often require fluorescent labeling to analyze cellular structures, which can be time-consuming and invasive. In contrast, our HT-X1 system allows for high-resolution visualization of cellular morphology without...

Seoul National University College of Medicine
Customer insight

Pioneering Spatial Protein Analysis in Korea: Advancing Clinical Pathology with Lambda Biologics’ Support

Traditional protein analysis has primarily focused on quantifying expression levels within tissue samples. However, recent advances in spatial analysis techniques have shifted attention toward evaluating not only expression levels, but...

K Research Institute
Customer insight

ODISEI-Gut Platform Reveals Immune-Boosting Potential of Kimchi-Derived Bacterial Strain

Among the many fermented foods we consume, kimchi is particularly known for containing a diverse range of lactic acid bacteria, which are believed to influence the activation of immune cells...

Bundang Jesaeng General Hospital
Customer insight

Multiplex Marker Analysis Enhances Research Efficiency with 31-Marker Detection on a Single Slide

We conducted a study focused on identifying disease-related markers using patient-derived tissue samples. However, traditional methods limited our ability to analyze multiple candidate markers simultaneously, and the limited availability of...

Description

Table of Contents

Generation of mature human liver organoid (hLO)

Liver organoids closely resemble human liver tissue, replicating both cell types and functions. EpCAM is expressed in hepatocytes and cholangiocytes, indicating epithelial cell adhesion and structural arrangement, while AFP is expressed in immature hepatocytes, reflecting developmental characteristics. Ki67 marks cell division, appearing in hepatocytes and progenitor cells, and ZO-1 is expressed in hepatocytes and cholangiocytes, assessing barrier function. HNF4A is expressed in hepatocytes and promotes hepatocyte differentiation and maturation, while E-cadherin (ECAD) maintains adhesion between hepatocytes and cholangiocytes, playing a key role in epithelial structure formation. These markers reflect the expression of various cell types in liver organoids, effectively mimicking the complex structure and function of human liver tissue.

Generation of Liver organoids

Cellular and structural similarity

Liver organoids can be observed in a mature form with hepatic layers, bile duct structures architecture similar to actual liver tissue.
They are also composed of various cells such as hepatocytes, cholangiocytes, Kupffer cells, stellate cells.

Expression markers
  • EpCAM Hepatic progenitor
  • ECAD Liver epithelial cells
  • AFP Immature hepatocyte
  • HNF4A Mature hepatocytes
  • ZO-1 Tight junctions
  • Ki67 Cell proliferation
  • FOXJ Mucous cells

Functional maturation of hLO

Gene expression
Expression markers
  • EpCAM Hepatic progenitor
  • ECAD Liver epithelial cells
  • AFP Immature hepatocyte
  • HNF4A Mature hepatocytes
  • ZO-1 Tight junctions
  • Ki67 Cell proliferation
  • FOXJ Mucous cells

Fatty Liver Model

Stage of liver disease

To induce a fatty liver model, we treated the liver organoids with free fatty acids.
It was confirmed that markers such as HNF4A, Albumin, and CYP3A4, which are indicative of healthy hepatocyte function, decreased in the damaged model.
This model can be used to evaluate effective substances related to fatty liver disease treatment.

Fatty acid accumulation in hLO

After treating liver organoids with fatty acids, a fatty liver model was created, and lipid accumulation was assessed using LipidTox staining at Day 3 and Day 7. The results showed that at Day 3, lipid accumulation was observed at an early stage, while at Day 7, lipid accumulation was significantly more pronounced. This indicates that, over time, the accumulation of lipids in the liver organoids increases, suggesting that this model effectively simulates the development of fatty liver and can be used as a valid model for research.

Connect with Us